124 related articles for article (PubMed ID: 14506958)
1. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors.
Taira H; Fujikawa Y; Kudo O; Itonaga I; Torisu T
Calcif Tissue Int; 2003 Jul; 73(1):78-85. PubMed ID: 14506958
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of vitamin K on RANKL-induced osteoclast differentiation and bone resorption.
Wu WJ; Kim MS; Ahn BY
Food Funct; 2015 Oct; 6(10):3351-8. PubMed ID: 26267519
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
5. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro.
Kawashima M; Fujikawa Y; Itonaga I; Takita C; Tsumura H
Mod Rheumatol; 2009; 19(2):192-8. PubMed ID: 19198759
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures.
Akiyama Y; Hara K; Tajima T; Murota S; Morita I
Eur J Pharmacol; 1994 Sep; 263(1-2):181-5. PubMed ID: 7821350
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
8. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner.
Hiruma Y; Nakahama K; Fujita H; Morita I
Biochem Biophys Res Commun; 2004 Jan; 314(1):24-30. PubMed ID: 14715241
[TBL] [Abstract][Full Text] [Related]
10. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.
Otsuka E; Notoya M; Hagiwara H
Calcif Tissue Int; 2003 Jul; 73(1):72-7. PubMed ID: 14506957
[TBL] [Abstract][Full Text] [Related]
11. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts.
Ahn SJ; Baek JM; Cheon YH; Park SH; Lee MS; Oh J; Kim JY
Am J Chin Med; 2015; 43(4):715-29. PubMed ID: 26119955
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of osteoclast formation by inflammatory synovial fluid.
Adamopoulos IE; Danks L; Itonaga I; Locklin RM; Sabokbar A; Ferguson DJ; Athanasou NA
Virchows Arch; 2006 Jul; 449(1):69-77. PubMed ID: 16642388
[TBL] [Abstract][Full Text] [Related]
16. A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.
Amano S; Sekine K; Bonewald LF; Ohmori Y
J Cell Physiol; 2009 Oct; 221(1):40-53. PubMed ID: 19492422
[TBL] [Abstract][Full Text] [Related]
17. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
[TBL] [Abstract][Full Text] [Related]
18. Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity.
Kreja L; Liedert A; Schmidt C; Claes L; Ignatius A
J Mol Histol; 2007 Aug; 38(4):341-5. PubMed ID: 17576525
[TBL] [Abstract][Full Text] [Related]
19. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
20. Gender- and age-related differences in osteoclast formation from circulating precursors.
Jevon M; Sabokbar A; Fujikawa Y; Hirayama T; Neale SD; Wass J; Athanasou NA
J Endocrinol; 2002 Mar; 172(3):673-81. PubMed ID: 11874715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]